These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29775411)

  • 1. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.
    Lue Y; Gao C; Swerdloff R; Hoang J; Avetisyan R; Jia Y; Rao M; Ren S; Atienza V; Yu J; Zhang Y; Chen M; Song Y; Wang Y; Wang C
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H634-H643. PubMed ID: 29775411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury.
    Zhen J; Yu H; Ji H; Cai L; Leng J; Keller BB
    Life Sci; 2019 Dec; 239():117070. PubMed ID: 31751580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice.
    Qin Q; Mehta H; Yen K; Navarrete G; Brandhorst S; Wan J; Delrio S; Zhang X; Lerman LO; Cohen P; Lerman A
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1127-H1136. PubMed ID: 30004252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
    Deng S; Yan T; Jendrny C; Nemecek A; Vincetic M; Gödtel-Armbrust U; Wojnowski L
    BMC Cancer; 2014 Nov; 14():842. PubMed ID: 25406834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p.
    Yu X; Ruan Y; Shen T; Qiu Q; Yan M; Sun S; Dou L; Huang X; Wang Q; Zhang X; Man Y; Tang W; Jin Z; Li J
    Biomed Res Int; 2020; 2020():5107193. PubMed ID: 32190669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
    Zhang S; Meng T; Liu J; Zhang X; Zhang J
    Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice.
    Vijay V; Moland CL; Han T; Fuscoe JC; Lee T; Herman EH; Jenkins GR; Lewis SM; Cummings CA; Gao Y; Cao Z; Yu LR; Desai VG
    Toxicol Appl Pharmacol; 2016 Mar; 295():68-84. PubMed ID: 26873546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes.
    Yu X; Ruan Y; Huang X; Dou L; Lan M; Cui J; Chen B; Gong H; Wang Q; Yan M; Sun S; Qiu Q; Zhang X; Man Y; Tang W; Li J; Shen T
    Biochem Biophys Res Commun; 2020 Feb; 523(1):140-146. PubMed ID: 31837803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.
    Schuler MK; Gerdes S; West A; Richter S; Busemann C; Hentschel L; Lenz F; Kopp HG; Ehninger G; Reichardt P; Pink D
    BMC Cancer; 2016 Aug; 16():619. PubMed ID: 27507014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A QSAR study that compares the ability of bisdioxopiperazine analogs of the doxorubicin cardioprotective agent dexrazoxane (ICRF-187) to protect myocytes with DNA topoisomerase II inhibition.
    Hasinoff BB; Patel D; Wu X
    Toxicol Appl Pharmacol; 2020 Jul; 399():115038. PubMed ID: 32417440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.
    QuanJun Y; GenJin Y; LiLi W; YongLong H; Yan H; Jie L; JinLu H; Jin L; Run G; Cheng G
    PLoS One; 2017; 12(1):e0169567. PubMed ID: 28072830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F
    Desai VG; Lee T; Moland CL; Vijay V; Han T; Lewis SM; Herman EH; Fuscoe JC
    Toxicol Appl Pharmacol; 2019 Jan; 363():164-173. PubMed ID: 30517846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
    Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
    Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
    Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice.
    Bosman M; Krüger DN; Favere K; De Meyer GRY; Franssen C; Van Craenenbroeck EM; Guns PJ
    PLoS One; 2023; 18(11):e0294848. PubMed ID: 38015959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
    Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic Acid Riboside Regulates Nrf-2/P62-Related Oxidative Stress and Autophagy to Attenuate Doxorubicin-Induced Cardiomyocyte Injury.
    Zou L; Liang B; Gao Y; Ye T; Li M; Zhang Y; Lu Q; Hu X; Li H; Yuan Y; Xing D
    Biomed Res Int; 2022; 2022():6293329. PubMed ID: 35242876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin.
    Bishop S; Liu SJ
    Phytomedicine; 2017 Dec; 36():210-216. PubMed ID: 29157817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
    Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
    Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.